×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Arcutis Biotherapeutics Inc. (ARQT) NASDAQ

$9.91 0.32 (3.34%)

Market Cap: $959.42M

As of 03/28/24 04:00 PM EDT. Market closed.

(ARQT)

Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ

$9.91
0.32 (3.34%)

Market Cap: $959.42M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 ... read more

arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 for the treatment of seborrheic dermatitis and scalp psoriasis; arq-252, a selective topical small molecule inhibitor of janus kinase type 1 for hand eczema and other inflammatory dermatoses; and arq-255, a topical formulation of arq-252 designed to reach deeper into the skin to the postulated site of inflammation in alopecia areata. the company was formerly known as arcutis, inc. and changed its name to arcutis biotherapeutics, inc. in october 2019. arcutis biotherapeutics, inc. was founded in 2016 and is headquartered in westlake village, california. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
PRICE CHART FOR ARCUTIS BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.66
Previous Close
$9.59
Days Range
$9.30 - $9.81
52 week range
$1.76 - $15.40
Volume
3,723,645
Avg. Volume (30 days)
4,603,119
Market Cap
$959.42M
Dividend Yield
-
P/E
(3.66)
Shares Outstanding
96,813,363
Open
$9.66
Previous Close
$9.59
Days Range
$9.30 - $9.81
52 week range
$1.76 - $15.40
Volume
3,723,645
Avg. Volume (30 days)
4,603,119
Market Cap
$959.42M
Dividend Yield
-
P/E
(3.66)
Shares Outstanding
96,813,363
FINANCIAL STATEMENTS FOR ARCUTIS BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARCUTIS BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Matsuda MasaruSee RemarkMar 04, 2024 Sale$11.123,76041,816190,424Mar 06, 2024, 05:14 PM
Burnett PatrickSee RemarksMar 04, 2024 Sale$11.124,78253,182269,300Mar 06, 2024, 05:12 PM
Watanabe Todd FranklinSee RemarksMar 04, 2024 Sale$11.1214,903165,739874,533Mar 06, 2024, 05:09 PM
Moore Matthew RichardSVP and Chief Business OfficerMar 04, 2024 Sale$11.123,46838,568146,020Mar 06, 2024, 05:08 PM
Heron Patrick JDirectorMar 04, 2024 Buy$9.5021,052199,9948,785,284Mar 06, 2024, 04:28 PM
Burnett PatrickSee RemarksJan 02, 2024 Sale$3.541,3254,69257,032Jan 03, 2024, 05:30 PM
Watanabe Todd FranklinSee RemarksDec 01, 2023 Option Exercise$1.6859,525100,038513,682Dec 01, 2023, 08:51 PM
Watanabe Todd FranklinSee RemarksMay 31, 2023 Buy$6.381,4639,334515,145Dec 01, 2023, 08:51 PM
Matsuda MasaruSee RemarkNov 21, 2023 Sale$1.981,8503,66146,634Nov 21, 2023, 05:47 PM
Frazier Life Sciences VIII, L.P.10% OwnerOct 24, 2023 Buy$2.5080,000200,0008,764,232Oct 26, 2023, 04:09 PM
Burnett PatrickSee RemarksAug 21, 2023 Sale$7.041,60511,30259,662Aug 22, 2023, 12:24 PM
Matsuda MasaruSee RemarkMay 31, 2023 Option Exercise$6.381,4639,33443,609Jun 02, 2023, 08:31 PM
Matsuda MasaruSee RemarkMay 31, 2023 Sale$7.801,83014,27842,146Jun 02, 2023, 08:31 PM
Welgus Howard G.DirectorApr 17, 2023 Option Exercise$1.688,50014,285174,325Apr 18, 2023, 07:00 PM
Welgus Howard G.DirectorApr 17, 2023 Sale$13.978,500118,728165,825Apr 18, 2023, 07:00 PM
Welgus Howard G.DirectorApr 06, 2023 Option Exercise$1.688,50014,285174,325Apr 10, 2023, 04:13 PM
Welgus Howard G.DirectorApr 06, 2023 Sale$12.018,500102,085165,825Apr 10, 2023, 04:13 PM
Watanabe Todd FranklinSee RemarksMar 06, 2023 Sale$15.262,43537,167366,657Mar 08, 2023, 04:29 PM
Burrows Scott LChief Financial OfficerMar 06, 2023 Sale$15.262914,44259,115Mar 08, 2023, 04:29 PM
Burnett PatrickSee RemarksMar 06, 2023 Sale$15.2685112,98959,962Mar 08, 2023, 04:28 PM
Turney Patricia A.SVP, OperationsMar 06, 2023 Sale$15.2683112,68462,862Mar 08, 2023, 04:26 PM
OSBORNE DAVID WChief Technical OfficerMar 06, 2023 Sale$15.2669010,532268,854Mar 08, 2023, 04:26 PM
Lock Kenneth A.Chief Commercial OfficerMar 06, 2023 Sale$15.2683112,68463,429Mar 08, 2023, 04:25 PM
Moore Matthew RichardSee RemarksMar 02, 2023 Sale$15.831,61025,48111,711Mar 06, 2023, 06:54 PM
Matsuda MasaruSee RemarksMar 02, 2023 Sale$15.831,43422,69618,119Mar 06, 2023, 06:52 PM
Burnett PatrickSee RemarksMar 02, 2023 Sale$15.831,75127,71339,836Mar 06, 2023, 06:51 PM
Turney Patricia A.SVP, OperationsFeb 28, 2023 Sale$16.1793615,13247,125Mar 02, 2023, 07:07 PM
Turney Patricia A.SVP, OperationsMar 02, 2023 Sale$15.831,43222,66445,711Mar 02, 2023, 07:07 PM
Watanabe Todd FranklinSee RemarksMar 02, 2023 Sale$15.835,47286,606369,161Mar 02, 2023, 07:06 PM
Watanabe Todd FranklinSee RemarksFeb 28, 2023 Sale$16.172,34337,878374,564Mar 02, 2023, 07:06 PM
Burrows Scott LChief Financial OfficerMar 02, 2023 Sale$15.831,43422,69638,424Mar 02, 2023, 07:05 PM
Burrows Scott LChief Financial OfficerFeb 28, 2023 Sale$16.174166,72539,840Mar 02, 2023, 07:05 PM
Lock Kenneth A.Chief Commercial OfficerMar 02, 2023 Sale$15.831,43222,66443,278Mar 02, 2023, 07:04 PM
Lock Kenneth A.Chief Commercial OfficerFeb 28, 2023 Sale$16.1793615,13244,692Mar 02, 2023, 07:04 PM
OSBORNE DAVID WChief Technical OfficerMar 02, 2023 Sale$15.831,21319,198254,659Mar 02, 2023, 07:03 PM
OSBORNE DAVID WChief Technical OfficerFeb 28, 2023 Sale$16.1779212,804255,857Mar 02, 2023, 07:03 PM
Welgus Howard G.DirectorFeb 15, 2023 Option Exercise$1.688,50014,285174,325Feb 21, 2023, 07:20 AM
Welgus Howard G.DirectorFeb 15, 2023 Sale$16.988,500144,352165,825Feb 21, 2023, 07:20 AM
Watanabe Todd FranklinSee RemarksFeb 14, 2023 Sale$17.025178,800377,007Feb 15, 2023, 07:09 PM
Watanabe Todd FranklinSee RemarksFeb 13, 2023 Sale$17.004838,211377,466Feb 15, 2023, 07:09 PM
Watanabe Todd FranklinSee RemarksFeb 01, 2023 Sale$17.001,00017,003378,289Feb 03, 2023, 04:26 PM
Welgus Howard G.DirectorJan 17, 2023 Option Exercise$1.688,50014,280174,325Jan 18, 2023, 08:18 PM
Welgus Howard G.DirectorJan 17, 2023 Sale$13.728,500116,655165,825Jan 18, 2023, 08:18 PM
Burnett PatrickSee RemarksJan 03, 2023 Sale$15.011,47522,13641,564Jan 04, 2023, 05:15 PM
Watanabe Todd FranklinSee RemarksDec 07, 2022 Sale$17.061,00017,060378,907Dec 09, 2022, 04:47 PM
Matsuda MasaruSee RemarkNov 21, 2022 Sale$18.191,72031,28919,535Nov 22, 2022, 07:06 PM
Welgus Howard G.DirectorNov 15, 2022 Option Exercise$1.681,0201,714169,228Nov 17, 2022, 04:29 PM
Welgus Howard G.DirectorNov 15, 2022 Sale$20.013,40368,103165,825Nov 17, 2022, 04:29 PM
Watanabe Todd FranklinSee RemarksNov 07, 2022 Sale$18.001,00018,004379,907Nov 09, 2022, 04:39 PM
Watanabe Todd FranklinPresident and CEOOct 07, 2022 Sale$19.511,00019,510380,907Oct 11, 2022, 06:47 PM
Welgus Howard G.DirectorOct 04, 2022 Sale$20.296,000121,766168,208Oct 06, 2022, 04:26 PM
Burrows Scott LChief Financial OfficerSep 16, 2022 Option Exercise$1.685,0008,40340,256Sep 20, 2022, 04:37 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2022 Sale$21.511,00021,510381,907Sep 09, 2022, 05:10 PM
Welgus Howard G.DirectorAug 15, 2022 Sale$24.806,000148,789174,208Aug 17, 2022, 05:06 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2022 Option Exercise$1.682,5004,202654,371Aug 09, 2022, 05:16 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2022 Sale$24.742,50061,858651,871Aug 09, 2022, 05:16 PM
Frazier Life Sciences VIII, L.P.10% OwnerAug 05, 2022 Buy$20.00250,0005,000,0008,684,232Aug 09, 2022, 04:34 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5215,33199,95846,444Aug 04, 2022, 08:42 PM
Welgus Howard G.DirectorJul 18, 2022 Sale$24.406,000146,374180,208Jul 18, 2022, 06:53 PM
OSBORNE DAVID WChief Technical OfficerJul 08, 2022 Sale$25.412,19755,835256,649Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 08, 2022 Option Exercise$1.687,08711,910658,958Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 08, 2022 Sale$25.3713,500342,473656,784Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2022 Sale$22.071,00022,070658,284Jul 07, 2022, 04:04 PM
ORBIMED ADVISORS LLC10% OwnerJun 24, 2022 Sale$21.31341,9717,287,4023,534,537Jun 28, 2022, 04:29 PM
Watanabe Todd FranklinPresident and CEOJun 06, 2022 Sale$21.061,00021,064659,284Jun 06, 2022, 04:06 PM
Matsuda MasaruSVP and General CounselJun 02, 2022 Sale$19.731,79535,41916,380Jun 02, 2022, 04:48 PM
Welgus Howard G.DirectorJun 01, 2022 Option Exercise$1.682,5004,202184,396Jun 02, 2022, 04:48 PM
Welgus Howard G.DirectorJun 01, 2022 Sale$20.622,50051,539181,896Jun 02, 2022, 04:48 PM
Watanabe Todd FranklinPresident and CEOMay 05, 2022 Sale$21.761,00021,760658,667May 05, 2022, 05:31 PM
Welgus Howard G.DirectorMay 02, 2022 Option Exercise$1.022,5002,555184,396May 03, 2022, 05:14 PM
Welgus Howard G.DirectorMay 02, 2022 Sale$20.442,50051,112181,896May 03, 2022, 05:14 PM
OSBORNE DAVID WChief Technical OfficerApr 21, 2022 Sale$20.422,19744,872257,229Apr 21, 2022, 06:32 PM
ORBIMED ADVISORS LLC10% OwnerApr 07, 2022 Sale$20.66344,9967,127,6173,937,764Apr 08, 2022, 06:06 PM
ORBIMED ADVISORS LLC10% OwnerApr 06, 2022 Sale$20.69333,2046,893,9914,105,564Apr 08, 2022, 06:06 PM
ORBIMED ADVISORS LLC10% OwnerApr 08, 2022 Sale$20.71200,0004,142,0003,840,564Apr 08, 2022, 06:06 PM
Watanabe Todd FranklinPresident and CEOApr 05, 2022 Sale$21.431,00021,430659,667Apr 05, 2022, 06:45 PM
Welgus Howard G.DirectorApr 01, 2022 Option Exercise$0.587,5004,352189,396Apr 01, 2022, 04:55 PM
Welgus Howard G.DirectorApr 01, 2022 Sale$20.027,500150,184181,896Apr 01, 2022, 04:55 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5225,328165,13956,441Mar 30, 2022, 08:02 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5225,328165,13956,441Mar 25, 2022, 04:11 PM
Watanabe Todd FranklinPresident and CEOMar 09, 2022 Sale$17.003005,100660,667Mar 11, 2022, 09:42 PM
Watanabe Todd FranklinPresident and CEOMar 07, 2022 Option Exercise$1.687001,176661,667Mar 07, 2022, 08:59 PM
Watanabe Todd FranklinPresident and CEOMar 07, 2022 Sale$17.0577013,125660,967Mar 07, 2022, 08:59 PM
Watanabe Todd FranklinPresident and CEOMar 04, 2022 Sale$16.862,48941,962661,037Mar 07, 2022, 08:59 PM
Burnett PatrickSee RemarksMar 04, 2022 Sale$16.8698116,53943,069Mar 07, 2022, 08:53 PM
Burnett PatrickSee RemarksMar 07, 2022 Sale$16.443049343,039Mar 07, 2022, 08:53 PM
Lock Kenneth A.Chief Commercial OfficerMar 07, 2022 Sale$16.443049344,011Mar 07, 2022, 08:49 PM
Lock Kenneth A.Chief Commercial OfficerMar 04, 2022 Sale$16.8699316,74144,041Mar 07, 2022, 08:49 PM
Burrows Scott LChief Financial OfficerMar 07, 2022 Sale$16.441016435,256Mar 07, 2022, 08:49 PM
Burrows Scott LChief Financial OfficerMar 04, 2022 Sale$16.862934,94035,266Mar 07, 2022, 08:49 PM
Turney Patricia A.SVP, OperationsMar 07, 2022 Sale$16.443049331,113Mar 07, 2022, 08:48 PM
Turney Patricia A.SVP, OperationsMar 04, 2022 Sale$16.8699316,74131,143Mar 07, 2022, 08:48 PM
OSBORNE DAVID WChief Technical OfficerMar 07, 2022 Sale$16.4428460259,426Mar 07, 2022, 08:47 PM
OSBORNE DAVID WChief Technical OfficerMar 04, 2022 Sale$16.8682813,959259,454Mar 07, 2022, 08:47 PM
Watanabe Todd FranklinPresident and CEOMar 01, 2022 Sale$17.752,15338,222592,626Mar 03, 2022, 04:18 PM
Lock Kenneth A.Chief Commercial OfficerMar 01, 2022 Sale$17.7593516,59931,734Mar 03, 2022, 04:15 PM
Watanabe Todd FranklinPresident and CEOFeb 09, 2022 Option Exercise$1.681,0001,681595,779Feb 11, 2022, 05:55 PM
Watanabe Todd FranklinPresident and CEOFeb 09, 2022 Sale$17.001,00017,000594,779Feb 11, 2022, 05:55 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2022 Option Exercise$1.681,0001,681595,779Jan 07, 2022, 04:17 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2022 Sale$21.591,00021,592595,479Jan 07, 2022, 04:17 PM
Welgus Howard G.DirectorJan 03, 2022 Option Exercise$0.582,5001,451184,396Jan 05, 2022, 05:19 PM
Welgus Howard G.DirectorJan 03, 2022 Sale$21.212,50053,029181,896Jan 05, 2022, 05:19 PM
Burrows Scott LChief Financial OfficerDec 27, 2021 Sale$20.0712,560252,13922,679Dec 28, 2021, 05:00 PM
Welgus Howard G.DirectorDec 23, 2021 Option Exercise$0.582,5001,451184,396Dec 23, 2021, 09:46 PM
Welgus Howard G.DirectorDec 23, 2021 Sale$20.162,50050,395181,896Dec 23, 2021, 09:46 PM
Watanabe Todd FranklinPresident and CEODec 08, 2021 Option Exercise$1.681,0001,681595,779Dec 10, 2021, 06:41 PM
Watanabe Todd FranklinPresident and CEODec 08, 2021 Sale$17.001,00017,000594,779Dec 10, 2021, 06:41 PM
Watanabe Todd FranklinPresident and CEONov 05, 2021 Option Exercise$1.681,0001,681595,779Nov 09, 2021, 05:19 PM
Watanabe Todd FranklinPresident and CEONov 05, 2021 Sale$21.501,00021,502594,779Nov 09, 2021, 05:19 PM
Welgus Howard G.DirectorNov 01, 2021 Option Exercise$0.582,5001,451184,396Nov 03, 2021, 05:16 PM
Welgus Howard G.DirectorNov 01, 2021 Sale$21.812,50054,524181,896Nov 03, 2021, 05:16 PM
Watanabe Todd FranklinPresident and CEOOct 05, 2021 Option Exercise$1.682,5004,202597,279Oct 07, 2021, 04:05 PM
Watanabe Todd FranklinPresident and CEOOct 05, 2021 Sale$24.922,50062,294594,779Oct 07, 2021, 04:05 PM
Welgus Howard G.DirectorOct 01, 2021 Option Exercise$0.582,5001,451184,396Oct 05, 2021, 02:11 PM
Welgus Howard G.DirectorOct 01, 2021 Sale$23.872,50059,680181,896Oct 05, 2021, 02:11 PM
Watanabe Todd FranklinPresident and CEOOct 01, 2021 Option Exercise$1.681,5002,521596,279Oct 05, 2021, 02:10 PM
Watanabe Todd FranklinPresident and CEOOct 01, 2021 Sale$25.011,50037,510594,779Oct 05, 2021, 02:10 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2021 Option Exercise$1.681,0001,681595,779Sep 09, 2021, 05:42 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2021 Sale$21.141,00021,137594,779Sep 09, 2021, 05:42 PM
Welgus Howard G.DirectorSep 01, 2021 Option Exercise$1.565,0007,791186,896Sep 03, 2021, 05:07 PM
Welgus Howard G.DirectorSep 01, 2021 Sale$20.805,000103,986182,696Sep 03, 2021, 05:07 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2021 Option Exercise$1.681,0001,681595,779Aug 09, 2021, 06:51 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2021 Sale$20.811,00020,810594,779Aug 09, 2021, 06:51 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2021 Option Exercise$1.681,7502,941596,529Jul 08, 2021, 07:40 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2021 Sale$26.581,75046,515594,779Jul 08, 2021, 07:40 PM
Welgus Howard G.DirectorJul 01, 2021 Option Exercise$3.942,2008,674184,096Jul 06, 2021, 07:14 PM
Welgus Howard G.DirectorJul 01, 2021 Sale$26.132,20057,476182,146Jul 06, 2021, 07:14 PM
CHAUDHURI BHASKARDirectorJun 25, 2021 Sale$27.506,755185,763841,391Jun 28, 2021, 04:11 PM
CHAUDHURI BHASKARDirectorJun 24, 2021 Sale$27.5072920,048848,146Jun 28, 2021, 04:11 PM
CHAUDHURI BHASKARDirectorJun 21, 2021 Sale$27.502,51669,190848,875Jun 23, 2021, 05:47 PM
Watanabe Todd FranklinPresident and CEOJun 07, 2021 Option Exercise$1.681,7502,941596,529Jun 09, 2021, 04:35 PM
Watanabe Todd FranklinPresident and CEOJun 07, 2021 Sale$26.351,75046,113594,779Jun 09, 2021, 04:35 PM
CHAUDHURI BHASKARDirectorApr 20, 2021 Sale$28.0610,000280,568862,671May 19, 2021, 06:43 PM
Watanabe Todd FranklinPresident and CEOMay 05, 2021 Option Exercise$1.681,6072,701595,523May 07, 2021, 11:29 AM
Watanabe Todd FranklinPresident and CEOMay 05, 2021 Sale$34.001,75059,500593,773May 07, 2021, 11:29 AM
Welgus Howard G.DirectorMay 03, 2021 Option Exercise$3.942,2008,674213,141May 05, 2021, 02:05 PM
Welgus Howard G.DirectorMay 03, 2021 Sale$34.792,20076,547211,858May 05, 2021, 02:05 PM
Watanabe Todd FranklinPresident and CEOApr 30, 2021 Sale$35.001,50052,500593,916May 04, 2021, 03:00 PM
CHAUDHURI BHASKARDirectorApr 20, 2021 Sale$28.0610,000280,568862,671Apr 22, 2021, 08:17 PM
Welgus Howard G.DirectorApr 16, 2021 Option Exercise$1.172,6553,117210,941Apr 20, 2021, 05:43 PM
CHAUDHURI BHASKARDirectorMar 22, 2021 Sale$31.1010,000311,021876,383Mar 24, 2021, 11:33 AM
Welgus Howard G.DirectorMar 16, 2021 Option Exercise$1.172,6533,114208,286Mar 18, 2021, 01:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Option Exercise$1.6850084046,821Mar 11, 2021, 03:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Sale$32.901,25041,12586,715Mar 11, 2021, 03:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Sale$32.9050016,45046,321Mar 11, 2021, 03:59 PM
Watanabe Todd FranklinPresident and CEOMar 05, 2021 Sale$30.551,75053,462597,166Mar 05, 2021, 03:56 PM
Smither John WChief Financial OfficerMar 04, 2021 Option Exercise$1.6812,39620,83346,321Mar 05, 2021, 03:55 PM
Watanabe Todd FranklinPresident and CEOMar 02, 2021 Sale$35.192,10774,136566,216Mar 03, 2021, 04:51 PM
OSBORNE DAVID WChief Technical OfficerMar 01, 2021 Sale$34.5778026,968237,253Mar 03, 2021, 04:50 PM
Turney Patricia A.SVP, OperationsMar 01, 2021 Sale$34.5293432,2429,271Mar 03, 2021, 04:49 PM
Smither John WChief Financial OfficerMar 01, 2021 Sale$34.2077326,44024,425Mar 03, 2021, 04:48 PM
Lock Kenneth A.Chief Commercial OfficerMar 01, 2021 Sale$34.2093331,90822,167Mar 03, 2021, 04:47 PM
Welgus Howard G.DirectorMar 01, 2021 Option Exercise$3.922,2008,626207,833Mar 03, 2021, 12:00 AM
Welgus Howard G.DirectorMar 01, 2021 Sale$34.372,20075,610205,799Mar 03, 2021, 12:00 AM
CHAUDHURI BHASKARDirectorFeb 22, 2021 Sale$35.5210,000355,191884,180Feb 24, 2021, 03:33 PM
Welgus Howard G.DirectorFeb 16, 2021 Option Exercise$1.172,6543,116205,633Feb 17, 2021, 08:35 PM
Smither John WChief Financial OfficerFeb 10, 2021 Option Exercise$1.687501,26025,948Feb 12, 2021, 05:32 PM
Smither John WChief Financial OfficerFeb 10, 2021 Sale$35.642,00071,28087,965Feb 12, 2021, 05:32 PM
Smither John WChief Financial OfficerFeb 10, 2021 Sale$35.6475026,73025,198Feb 12, 2021, 05:32 PM
Watanabe Todd FranklinPresident and CEOFeb 05, 2021 Option Exercise$1.6810,00016,806578,323Feb 08, 2021, 04:00 PM
Watanabe Todd FranklinPresident and CEOFeb 05, 2021 Sale$34.2910,000342,916575,023Feb 08, 2021, 04:00 PM
Welgus Howard G.DirectorFeb 04, 2021 Option Exercise$1.6819,86133,378202,979Feb 08, 2021, 01:45 PM
Welgus Howard G.DirectorFeb 01, 2021 Option Exercise$1.682,2003,697185,318Feb 03, 2021, 11:24 AM
Welgus Howard G.DirectorFeb 01, 2021 Sale$34.352,20075,572184,768Feb 03, 2021, 11:24 AM
Smither John WChief Financial OfficerFeb 01, 2021 Option Exercise$1.681,2502,10126,448Feb 03, 2021, 11:23 AM
Smither John WChief Financial OfficerFeb 01, 2021 Sale$35.003,750131,25089,965Feb 03, 2021, 11:23 AM
Smither John WChief Financial OfficerFeb 01, 2021 Sale$35.001,25043,75025,198Feb 03, 2021, 11:23 AM
CHAUDHURI BHASKARDirectorFeb 01, 2021 Sale$33.259,949330,804891,391Feb 02, 2021, 07:39 PM
CHAUDHURI BHASKARDirectorJan 29, 2021 Sale$27.50511,403901,340Feb 02, 2021, 07:39 PM
Smither John WChief Financial OfficerJan 19, 2021 Option Exercise$1.6850084025,698Jan 21, 2021, 04:41 PM
Smither John WChief Financial OfficerJan 19, 2021 Sale$30.001,25037,50093,715Jan 21, 2021, 04:41 PM
Smither John WChief Financial OfficerJan 19, 2021 Sale$30.0050015,00025,198Jan 21, 2021, 04:41 PM
Welgus Howard G.DirectorJan 12, 2021 Option Exercise$0.581,222709183,118Jan 14, 2021, 11:11 AM
Watanabe Todd FranklinPresident and CEOJan 05, 2021 Option Exercise$1.6810,00016,806578,323Jan 07, 2021, 03:13 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2021 Sale$28.0810,000280,754568,323Jan 07, 2021, 03:13 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Option Exercise$1.683,0005,042569,928Jan 07, 2021, 02:39 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Sale$30.003,00090,000566,928Jan 07, 2021, 02:39 PM
Welgus Howard G.DirectorJan 04, 2021 Option Exercise$1.682,2003,697184,096Jan 06, 2021, 01:16 PM
Welgus Howard G.DirectorJan 04, 2021 Sale$27.822,20061,215181,896Jan 06, 2021, 01:16 PM
OSBORNE DAVID WChief Technical OfficerDec 14, 2020 Sale$30.0015,000450,000250,533Dec 16, 2020, 03:15 PM
Smither John WChief Financial OfficerDec 14, 2020 Option Exercise$1.681,5002,52126,698Dec 16, 2020, 03:14 PM
Smither John WChief Financial OfficerDec 14, 2020 Sale$30.003,750112,50094,965Dec 16, 2020, 03:14 PM
Smither John WChief Financial OfficerDec 14, 2020 Sale$30.001,50045,00025,198Dec 16, 2020, 03:14 PM
Welgus Howard G.DirectorDec 14, 2020 Option Exercise$0.581,222709181,896Dec 16, 2020, 03:14 PM
Welgus Howard G.DirectorDec 01, 2020 Option Exercise$1.682,2003,696182,044Dec 03, 2020, 07:40 PM
Welgus Howard G.DirectorDec 01, 2020 Sale$25.982,20057,155181,157Dec 03, 2020, 07:40 PM
Welgus Howard G.DirectorNov 12, 2020 Option Exercise$0.581,222709179,844Nov 13, 2020, 11:57 AM
Welgus Howard G.DirectorNov 02, 2020 Option Exercise$1.682,2003,696180,822Nov 04, 2020, 04:33 PM
Welgus Howard G.DirectorNov 02, 2020 Sale$18.272,20040,186178,622Nov 04, 2020, 04:33 PM
Lock Kenneth A.Chief Commercial OfficerOct 26, 2020 Option Exercise$6.522,66817,39521,863Oct 27, 2020, 02:03 PM
Lock Kenneth A.Chief Commercial OfficerOct 22, 2020 Option Exercise$6.522,69517,57119,195Oct 23, 2020, 01:27 PM
Lock Kenneth A.Chief Commercial OfficerOct 15, 2020 Option Exercise$6.527,50048,90016,500Oct 16, 2020, 02:06 PM
Welgus Howard G.DirectorOct 15, 2020 Option Exercise$0.581,222709178,622Oct 16, 2020, 02:06 PM
ORBIMED ADVISORS LLCDirectorOct 02, 2020 Buy$25.00496,00012,400,0004,267,564Oct 06, 2020, 05:27 PM
SILVERSTEIN JONATHANDirectorOct 02, 2020 Buy$25.00496,00012,400,0004,267,564Oct 06, 2020, 05:23 PM
Welgus Howard G.DirectorOct 01, 2020 Option Exercise$1.682,2003,696179,210Oct 05, 2020, 09:13 PM
Welgus Howard G.DirectorOct 01, 2020 Sale$27.652,20060,829177,400Oct 05, 2020, 09:13 PM
Welgus Howard G.DirectorSep 01, 2020 Option Exercise$1.682,2003,696177,350Oct 05, 2020, 09:12 PM
Welgus Howard G.DirectorSep 01, 2020 Sale$24.382,20053,643176,178Oct 05, 2020, 09:12 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Option Exercise$1.683,0005,042569,928Oct 01, 2020, 09:02 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Sale$30.003,00090,000566,928Oct 01, 2020, 09:02 PM
OSBORNE DAVID WChief Technical OfficerSep 29, 2020 Sale$30.0015,000450,000264,279Oct 01, 2020, 09:01 PM
Smither John WChief Financial OfficerSep 29, 2020 Option Exercise$1.6850084024,375Oct 01, 2020, 09:00 PM
Smither John WChief Financial OfficerSep 29, 2020 Sale$30.001,25037,50098,715Oct 01, 2020, 09:00 PM
Smither John WChief Financial OfficerSep 29, 2020 Sale$30.0050015,00023,875Oct 01, 2020, 09:00 PM
Welgus Howard G.DirectorSep 15, 2020 Option Exercise$0.581,222709177,400Sep 16, 2020, 05:57 PM
Welgus Howard G.DirectorSep 01, 2020 Option Exercise$1.682,2003,696178,378Sep 02, 2020, 11:48 AM
Welgus Howard G.DirectorSep 01, 2020 Sale$24.382,20053,643176,178Sep 02, 2020, 11:48 AM
Welgus Howard G.DirectorAug 20, 2020 Option Exercise$1.685,0008,400176,178Aug 21, 2020, 02:19 PM
Welgus Howard G.DirectorAug 18, 2020 Option Exercise$1.685,0768,528171,178Aug 19, 2020, 05:48 PM
Welgus Howard G.DirectorAug 14, 2020 Option Exercise$0.586,1103,545166,102Aug 18, 2020, 04:12 PM
Welgus Howard G.DirectorAug 03, 2020 Option Exercise$1.682,8004,704162,725Aug 05, 2020, 05:11 PM
Welgus Howard G.DirectorAug 03, 2020 Sale$25.632,80071,764159,992Aug 05, 2020, 05:11 PM
Smither John WChief Financial OfficerJun 11, 2020 Option Exercise$1.6814,87524,999123,840Jun 15, 2020, 03:15 PM
Watanabe Todd FranklinPresident and CEOMar 13, 2020 Option Exercise$1.6859,48199,964566,928Mar 16, 2020, 06:05 PM
Welgus Howard G.Chief Medical OfficerMar 12, 2020 Option Exercise$0.586,1103,545159,992Mar 16, 2020, 06:04 PM
Bain Capital Life Sciences Investors, LLC10% OwnerFeb 04, 2020 Buy$17.00294,1174,999,9893,979,292Feb 06, 2020, 04:26 PM
Heron Patrick JDirectorFeb 04, 2020 Buy$17.00500,0008,500,00010,542,790Feb 06, 2020, 11:27 AM
Frazier Life Sciences VIII, L.P.10% OwnerFeb 04, 2020 Buy$17.00500,0008,500,00010,542,790Feb 06, 2020, 10:29 AM
ORBIMED ADVISORS LLCDirectorFeb 03, 2020 Buy$17.00558,8889,501,096382,388Feb 04, 2020, 05:30 PM
SILVERSTEIN JONATHANDirectorFeb 03, 2020 Buy$17.00558,8889,501,096382,388Feb 04, 2020, 05:27 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Matsuda MasaruSee Remark03/04/202441,816
Burnett PatrickSee Remarks03/04/202453,182
Watanabe Todd FranklinSee Remarks03/04/2024165,739
Moore Matthew RichardSVP and Chief Business Officer03/04/202438,568
Heron Patrick JDirector03/04/2024199,994
Burnett PatrickSee Remarks01/02/20244,692
Watanabe Todd FranklinSee Remarks12/01/2023100,038
Watanabe Todd FranklinSee Remarks05/31/20239,334
Matsuda MasaruSee Remark11/21/20233,661
Frazier Life Sciences VIII, L.P.10% Owner10/24/2023200,000
Burnett PatrickSee Remarks08/21/202311,302
Matsuda MasaruSee Remark05/31/20239,334
Matsuda MasaruSee Remark05/31/202314,278
Welgus Howard G.Director04/17/202314,285
Welgus Howard G.Director04/17/2023118,728
Welgus Howard G.Director04/06/202314,285
Welgus Howard G.Director04/06/2023102,085
Watanabe Todd FranklinSee Remarks03/06/202337,167
Burrows Scott LChief Financial Officer03/06/20234,442
Burnett PatrickSee Remarks03/06/202312,989
Turney Patricia A.SVP, Operations03/06/202312,684
OSBORNE DAVID WChief Technical Officer03/06/202310,532
Lock Kenneth A.Chief Commercial Officer03/06/202312,684
Moore Matthew RichardSee Remarks03/02/202325,481
Matsuda MasaruSee Remarks03/02/202322,696
Burnett PatrickSee Remarks03/02/202327,713
Turney Patricia A.SVP, Operations02/28/202315,132
Turney Patricia A.SVP, Operations03/02/202322,664
Watanabe Todd FranklinSee Remarks03/02/202386,606
Watanabe Todd FranklinSee Remarks02/28/202337,878
Burrows Scott LChief Financial Officer03/02/202322,696
Burrows Scott LChief Financial Officer02/28/20236,725
Lock Kenneth A.Chief Commercial Officer03/02/202322,664
Lock Kenneth A.Chief Commercial Officer02/28/202315,132
OSBORNE DAVID WChief Technical Officer03/02/202319,198
OSBORNE DAVID WChief Technical Officer02/28/202312,804
Welgus Howard G.Director02/15/202314,285
Welgus Howard G.Director02/15/2023144,352
Watanabe Todd FranklinSee Remarks02/14/20238,800
Watanabe Todd FranklinSee Remarks02/13/20238,211
Watanabe Todd FranklinSee Remarks02/01/202317,003
Welgus Howard G.Director01/17/202314,280
Welgus Howard G.Director01/17/2023116,655
Burnett PatrickSee Remarks01/03/202322,136
Watanabe Todd FranklinSee Remarks12/07/202217,060
Matsuda MasaruSee Remark11/21/202231,289
Welgus Howard G.Director11/15/20221,714
Welgus Howard G.Director11/15/202268,103
Watanabe Todd FranklinSee Remarks11/07/202218,004
Watanabe Todd FranklinPresident and CEO10/07/202219,510
Welgus Howard G.Director10/04/2022121,766
Burrows Scott LChief Financial Officer09/16/20228,403
Watanabe Todd FranklinPresident and CEO09/07/202221,510
Welgus Howard G.Director08/15/2022148,789
Watanabe Todd FranklinPresident and CEO08/05/20224,202
Watanabe Todd FranklinPresident and CEO08/05/202261,858
Frazier Life Sciences VIII, L.P.10% Owner08/05/20225,000,000
Turney Patricia A.SVP, Operations03/23/202299,958
Welgus Howard G.Director07/18/2022146,374
OSBORNE DAVID WChief Technical Officer07/08/202255,835
Watanabe Todd FranklinPresident and CEO07/08/202211,910
Watanabe Todd FranklinPresident and CEO07/08/2022342,473
Watanabe Todd FranklinPresident and CEO07/06/202222,070
ORBIMED ADVISORS LLC10% Owner06/24/20227,287,402
Watanabe Todd FranklinPresident and CEO06/06/202221,064
Matsuda MasaruSVP and General Counsel06/02/202235,419
Welgus Howard G.Director06/01/20224,202
Welgus Howard G.Director06/01/202251,539
Watanabe Todd FranklinPresident and CEO05/05/202221,760
Welgus Howard G.Director05/02/20222,555
Welgus Howard G.Director05/02/202251,112
OSBORNE DAVID WChief Technical Officer04/21/202244,872
ORBIMED ADVISORS LLC10% Owner04/07/20227,127,617
ORBIMED ADVISORS LLC10% Owner04/06/20226,893,991
ORBIMED ADVISORS LLC10% Owner04/08/20224,142,000
Watanabe Todd FranklinPresident and CEO04/05/202221,430
Welgus Howard G.Director04/01/20224,352
Welgus Howard G.Director04/01/2022150,184
Turney Patricia A.SVP, Operations03/23/2022165,139
Turney Patricia A.SVP, Operations03/23/2022165,139
Watanabe Todd FranklinPresident and CEO03/09/20225,100
Watanabe Todd FranklinPresident and CEO03/07/20221,176
Watanabe Todd FranklinPresident and CEO03/07/202213,125
Watanabe Todd FranklinPresident and CEO03/04/202241,962
Burnett PatrickSee Remarks03/04/202216,539
Burnett PatrickSee Remarks03/07/2022493
Lock Kenneth A.Chief Commercial Officer03/07/2022493
Lock Kenneth A.Chief Commercial Officer03/04/202216,741
Burrows Scott LChief Financial Officer03/07/2022164
Burrows Scott LChief Financial Officer03/04/20224,940
Turney Patricia A.SVP, Operations03/07/2022493
Turney Patricia A.SVP, Operations03/04/202216,741
OSBORNE DAVID WChief Technical Officer03/07/2022460
OSBORNE DAVID WChief Technical Officer03/04/202213,959
Watanabe Todd FranklinPresident and CEO03/01/202238,222
Lock Kenneth A.Chief Commercial Officer03/01/202216,599
Watanabe Todd FranklinPresident and CEO02/09/20221,681
Watanabe Todd FranklinPresident and CEO02/09/202217,000
Watanabe Todd FranklinPresident and CEO01/05/20221,681
Watanabe Todd FranklinPresident and CEO01/05/202221,592
Welgus Howard G.Director01/03/20221,451
Welgus Howard G.Director01/03/202253,029
Burrows Scott LChief Financial Officer12/27/2021252,139
Welgus Howard G.Director12/23/20211,451
Welgus Howard G.Director12/23/202150,395
Watanabe Todd FranklinPresident and CEO12/08/20211,681
Watanabe Todd FranklinPresident and CEO12/08/202117,000
Watanabe Todd FranklinPresident and CEO11/05/20211,681
Watanabe Todd FranklinPresident and CEO11/05/202121,502
Welgus Howard G.Director11/01/20211,451
Welgus Howard G.Director11/01/202154,524
Watanabe Todd FranklinPresident and CEO10/05/20214,202
Watanabe Todd FranklinPresident and CEO10/05/202162,294
Welgus Howard G.Director10/01/20211,451
Welgus Howard G.Director10/01/202159,680
Watanabe Todd FranklinPresident and CEO10/01/20212,521
Watanabe Todd FranklinPresident and CEO10/01/202137,510
Watanabe Todd FranklinPresident and CEO09/07/20211,681
Watanabe Todd FranklinPresident and CEO09/07/202121,137
Welgus Howard G.Director09/01/20217,791
Welgus Howard G.Director09/01/2021103,986
Watanabe Todd FranklinPresident and CEO08/05/20211,681
Watanabe Todd FranklinPresident and CEO08/05/202120,810
Watanabe Todd FranklinPresident and CEO07/06/20212,941
Watanabe Todd FranklinPresident and CEO07/06/202146,515
Welgus Howard G.Director07/01/20218,674
Welgus Howard G.Director07/01/202157,476
CHAUDHURI BHASKARDirector06/25/2021185,763
CHAUDHURI BHASKARDirector06/24/202120,048
CHAUDHURI BHASKARDirector06/21/202169,190
Watanabe Todd FranklinPresident and CEO06/07/20212,941
Watanabe Todd FranklinPresident and CEO06/07/202146,113
CHAUDHURI BHASKARDirector04/20/2021280,568
Watanabe Todd FranklinPresident and CEO05/05/20212,701
Watanabe Todd FranklinPresident and CEO05/05/202159,500
Welgus Howard G.Director05/03/20218,674
Welgus Howard G.Director05/03/202176,547
Watanabe Todd FranklinPresident and CEO04/30/202152,500
CHAUDHURI BHASKARDirector04/20/2021280,568
Welgus Howard G.Director04/16/20213,117
CHAUDHURI BHASKARDirector03/22/2021311,021
Welgus Howard G.Director03/16/20213,114
Smither John WChief Financial Officer03/10/2021840
Smither John WChief Financial Officer03/10/202141,125
Smither John WChief Financial Officer03/10/202116,450
Watanabe Todd FranklinPresident and CEO03/05/202153,462
Smither John WChief Financial Officer03/04/202120,833
Watanabe Todd FranklinPresident and CEO03/02/202174,136
OSBORNE DAVID WChief Technical Officer03/01/202126,968
Turney Patricia A.SVP, Operations03/01/202132,242
Smither John WChief Financial Officer03/01/202126,440
Lock Kenneth A.Chief Commercial Officer03/01/202131,908
Welgus Howard G.Director03/01/20218,626
Welgus Howard G.Director03/01/202175,610
CHAUDHURI BHASKARDirector02/22/2021355,191
Welgus Howard G.Director02/16/20213,116
Smither John WChief Financial Officer02/10/20211,260
Smither John WChief Financial Officer02/10/202171,280
Smither John WChief Financial Officer02/10/202126,730
Watanabe Todd FranklinPresident and CEO02/05/202116,806
Watanabe Todd FranklinPresident and CEO02/05/2021342,916
Welgus Howard G.Director02/04/202133,378
Welgus Howard G.Director02/01/20213,697
Welgus Howard G.Director02/01/202175,572
Smither John WChief Financial Officer02/01/20212,101
Smither John WChief Financial Officer02/01/2021131,250
Smither John WChief Financial Officer02/01/202143,750
CHAUDHURI BHASKARDirector02/01/2021330,804
CHAUDHURI BHASKARDirector01/29/20211,403
Smither John WChief Financial Officer01/19/2021840
Smither John WChief Financial Officer01/19/202137,500
Smither John WChief Financial Officer01/19/202115,000
Welgus Howard G.Director01/12/2021709
Watanabe Todd FranklinPresident and CEO01/05/202116,806
Watanabe Todd FranklinPresident and CEO01/05/2021280,754
Watanabe Todd FranklinPresident and CEO09/29/20205,042
Watanabe Todd FranklinPresident and CEO09/29/202090,000
Welgus Howard G.Director01/04/20213,697
Welgus Howard G.Director01/04/202161,215
OSBORNE DAVID WChief Technical Officer12/14/2020450,000
Smither John WChief Financial Officer12/14/20202,521
Smither John WChief Financial Officer12/14/2020112,500
Smither John WChief Financial Officer12/14/202045,000
Welgus Howard G.Director12/14/2020709
Welgus Howard G.Director12/01/20203,696
Welgus Howard G.Director12/01/202057,155
Welgus Howard G.Director11/12/2020709
Welgus Howard G.Director11/02/20203,696
Welgus Howard G.Director11/02/202040,186
Lock Kenneth A.Chief Commercial Officer10/26/202017,395
Lock Kenneth A.Chief Commercial Officer10/22/202017,571
Lock Kenneth A.Chief Commercial Officer10/15/202048,900
Welgus Howard G.Director10/15/2020709
ORBIMED ADVISORS LLCDirector10/02/202012,400,000
SILVERSTEIN JONATHANDirector10/02/202012,400,000
Welgus Howard G.Director10/01/20203,696
Welgus Howard G.Director10/01/202060,829
Welgus Howard G.Director09/01/20203,696
Welgus Howard G.Director09/01/202053,643
Watanabe Todd FranklinPresident and CEO09/29/20205,042
Watanabe Todd FranklinPresident and CEO09/29/202090,000
OSBORNE DAVID WChief Technical Officer09/29/2020450,000
Smither John WChief Financial Officer09/29/2020840
Smither John WChief Financial Officer09/29/202037,500
Smither John WChief Financial Officer09/29/202015,000
Welgus Howard G.Director09/15/2020709
Welgus Howard G.Director09/01/20203,696
Welgus Howard G.Director09/01/202053,643
Welgus Howard G.Director08/20/20208,400
Welgus Howard G.Director08/18/20208,528
Welgus Howard G.Director08/14/20203,545
Welgus Howard G.Director08/03/20204,704
Welgus Howard G.Director08/03/202071,764
Smither John WChief Financial Officer06/11/202024,999
Watanabe Todd FranklinPresident and CEO03/13/202099,964
Welgus Howard G.Chief Medical Officer03/12/20203,545
Bain Capital Life Sciences Investors, LLC10% Owner02/04/20204,999,989
Heron Patrick JDirector02/04/20208,500,000
Frazier Life Sciences VIII, L.P.10% Owner02/04/20208,500,000
ORBIMED ADVISORS LLCDirector02/03/20209,501,096
SILVERSTEIN JONATHANDirector02/03/20209,501,096
Load More Insider Transactions
FUNDS WITH A POSITION IN ARCUTIS BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
SUVRETTA CAPITAL MANAGEMENT, LLC8,473,1011.24%646.38%Growth At A Reasonable Price
BLACKROCK INC.5,916,5460.00049%47.16%Other
ORBIMED ADVISORS LLC1,914,4790.22%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC1,743,5890.00059%67.98%Other
HOLOCENE ADVISORS, LP1,204,5380.03%ExitedGrowth At A Reasonable Price
RENAISSANCE TECHNOLOGIES LLC395,1000.00198%NewOther
AQR CAPITAL MANAGEMENT LLC289,0880.00176%NewOther
TUDOR INVESTMENT CORP ET AL45,4610.00242%ExitedEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.38,0690.00041%ExitedEvent Driven
BLACKSTONE INC.24,1440.00035%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ARCUTIS BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR ARCUTIS BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
12.28%
1Q
12/31/2023
06/30/2023
12.82%
2Q
12/31/2023
03/31/2023
13.30%
3Q
12/31/2023
12/31/2022
13.54%
4Q
12/31/2023
09/30/2022
21.39%
5Q
12/31/2023
06/30/2022
34.78%
6Q
12/31/2023
03/31/2022
37.20%
7Q
12/31/2023
12/31/2021
38.03%
8Q
12/31/2023
09/30/2021
38.34%
9Q
12/31/2023
06/30/2021
38.61%
10Q
12/31/2023
03/31/2021
46.58%
11Q
12/31/2023
09/30/2020
83.60%
13Q
12/31/2023
06/30/2020
84.39%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
12.28%
1Q
06/30/2023
12.82%
2Q
03/31/2023
13.30%
3Q
12/31/2022
13.54%
4Q
09/30/2022
21.39%
5Q
06/30/2022
34.78%
6Q
03/31/2022
37.20%
7Q
12/31/2021
38.03%
8Q
09/30/2021
38.34%
9Q
06/30/2021
38.61%
10Q
03/31/2021
46.58%
11Q
09/30/2020
83.60%
13Q
06/30/2020
84.39%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ARCUTIS BIOTHERAPEUTICS INC
LOADING...